Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Biopharma Speed Grant Initiative

Biopharma Speed Grant Initiative
Pre-clinical researchers in the field of oncology, immuno-oncology, autoimmune disorders and drug discovery technologies are invited to apply for the Merck KGaA Biopharma Speed Grant Initiative; a fast funding program. At Merck KGaA, we are dedicated to accelerating innovation and advancing science, and in doing so, we are fostering independent research by reducing financial hurdles for researchers. In case of a positive decision grant funding will be made available on your bank account 3 weeks after we received your application.
In order to apply for the Speed Grant Initiative, click here.
 
  • Applicants will keep all rights to results and respective IP. We can even help you to submit your patent application upon request. Find all details in the terms and conditions.
  • Health Care Professionals and researchers employed by Healthcare Organizations may not be funded by this initiative for formal and legal reasons.
  • Funding is available for pre-clinical research only and has to be requested by individual persons, no institution may be funded.
  • Merck KGaA Biopharma can accept or decline your application at its own discretion.
  • Information in the application is considered as non-confidential, please ensure you are allowed to disclose any information you share in the application form.

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.